Previous NewYork-Presbyterian Heart Newsletters

Back to Newsletters Main Page

Fall 2006

CONTENTS

• Cardiothoracic Surgeon as Interventionalist
  New fellowship combines training in interventional cardiology and surgery.
• Adaptive Vein Graft Arterialization
  Reducing remodeling with spironolactone.
• Alcohol Septal Ablation
  Treating hypertrophic cardiomyopathy.
• Transcatheter Cardiovascular Therapeutics
  2006 conference information.
• Faculty Highlights

Spring 2006

CONTENTS

• Sudden Cardiac Death
  Improved risk stratification, routine ICD implantation help beat the odds
• Managing Acute MI
  Reducing "door-to-balloon" time from the ER
• Cryoablation for Atrial Fibrillation
  Expanding benefits to a broader patient population
• Peripartum Cardiomyopathy
  Review of the current understanding of this mysterious form of heart failure
• CME: Coronary Artery Disease
• Evalve Update
  EVEREST II trial for percutaneous mitral valve repair
• Breaking News
  REVIVAL:
  Early successful results in trial of percutaneous aortic valve replacement

Fall 2005

CONTENTS

• SCCOR Grant Awarded
  Major research endeavor to enhance mechanical circulatory support devices for heart failure patients:
• Infection: Understanding and reducing the incidence of staphylococcal infections
• Coagulation: Developing a selective anticoagulant to prevent late bleeding
• Cell transplantation: Stimulating recovery of the native heart
• Left Ventricular Hypertrophy:
  Another Treatable Silent Killer?
• Cardiac MRI
  One-stop test identifies heart failure etiology, predicts outcomes
• Transcatheter Cardiovascular Therapeutics
  Highlights of this year's symposium

SPRING 2005

CONTENTS

• Angiogenesis Research
  Growth factors may hold the key to angiogenesis therapies for severe cardiovascular disease.
• LVADs for Heart Failure
  Evolution of devices boosts treatment of advanced heart failure: focus on Impella and InSync Sentry™.
• Ablation of Arrhythmias
  Catheter ablation provides successful, safe alternative to medical therapy for more arrhythmia patients.
• Low-Dose Statins
  Current use lags behind guidelines, despite evidence supporting aggressive management of cholesterol.
• Continuing Medical Education
  Advances in the Treatment of Coronary Artery Disease.

Fall 2004

CONTENTS

• Aortic Aneurysms: Gaining control before they strike
  • Expert Review: The latest in detection, monitoring, and treatment cover
  • Cerebral protection during aortic arch surgery
• Aneurysms in the Descending and Thoracoabdominal Aorta
  Testing and development of endovascular alternatives
• Aortic Aneurysms and Dissection in the Marfan Syndrome
  Recommendations to the cardiologist
• Evalve® Clinical Trial
  Mitral valve repair without surgery
• Research Review: Identifying the Genetic Causes of Aneurysm Disease
  Weill Cornell researchers use positional cloning techniques to identify single gene defects
• Continuing Medical Education
• Cardiovascular Interventional Therapy
  New recruits elevate clinical practice and research at NYPH

Spring 2004

CONTENTS

• End-Stage Heart Failure: Changes in Management
  A review of the latest medical, surgical, device and transplant options
• Adult Congenital HeartDisease
  • New programs in training and clinical care at NewYork-Presbyterian meet the unique demands of expanding patient population
  • Surgical advances: lessons from the past
  • Pregnancy in women with congenital heart disease
• Lupus and Cardiovascular Disease
  While the role of chronic inflammation becomes clearer, traditional risk factors of atherosclerosis warrant management in patients with SLE
• Cardiac Surgery in the Ultra-Elderly
  Performing heart surgery safely in patients over 90
• Continuing Medical Education
• Percutaneous Approach to Mitral Valve Surgery
  Trial of E-valve Cardiovascular Repair System at NewYork-Presbyterian

Fall 2003

CONTENTS

Special Feature

• Sudden Cardiac Death
  • Overview and etiologies
  • Advances in identifying high-risk patients
  • New developments in primary prevention
• Cardiac PET
  Wide range of clinical and research applications
• Drug Eluting Coronary Stents
  Elimination of in-stent restenosis, a reachable goal
• Cardiac Surgery Updates
  
  • Expanded uses of the surgical robot
  • Cryoablation for MAZE

Spring 2003

CONTENTS

Special Feature:

• Treating Atrial Fibrillation
  Innovations in medical, surgical, and cardioversion options at Weill Cornell and Columbia
• Biventricular Pacing
  Becoming standard therapy for some patients with congestive heart failure
• Valve Surgery
  Update on mitral and aortic repair and replacement
• Selective Anticoagulant Targets Factor IXa
  Highly promising agent prevents extravascular bleeding and reduces intracerebral hemorrhage

Fall 2002

CONTENTS

Special Feature:

• Angiogenesis Research
  Four approaches to reversing cardiovascular disease
• Higher Blood Pressures During Bypass Surgery
  Higher pressures reduce incidence of stroke and MI
• Congenital Heart Disease in the Adult
  Perspectives on a dynamic, evolving field
• Predicting and Preventing Sudden Death
  Superior test can now predict likelihood of fatal ventricular arrhythmias
• Robotic Cardiac Surgery
  Update on recent achievements at Columbia and Cornell

Spring 2002

CONTENTS

• Researchers Uncover First Genetic Locus of Marfan-like Syndrome
  Diagnostic criteria available for identifying presymptomatic cardiac patients
• Landmark REMATCH Trial Proves Benefits of Implanted Heart Pumps
  Successful longterm treatment of terminally ill heart failure patients
• Off-Pump CABG: A Viable Alternative for Coronary Revascularization?
  OPCAB trial tests benefits in multi-vessel CAD patients
• Comprehensive Blood Conservation Program
  Blood-saving techniques significantly reduce need for transfusions
• Researchers Develop New Method of Preventing Arrhythmias
  New technology stops alternans from progressing to malignant arrhythmias